A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Women With Previously Treated Non-metastatic Triple Negative Breast Cancer and Women With Previously Treated Non-metastatic Breast Cancer With a Confirmed BRCA Mutation.

Clinical trial NCT02639832 · UNKNOWN

Trial details

NCT number: NCT02639832
Sponsor: Cynvenio Biosystems
Status: UNKNOWN
Study type: OBSERVATIONAL

Triple Negative Breast Cancer Natural Killer Cells BRCA Mutation

Start date: 2015-12-01
Primary completion: 2019-12-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.